Benito Munoz
64Patents
8h-index
133Co-inventors
81Inventor score
Filing activity: Jun 17, 1993 → Nov 18, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9745292B2 | Compounds, compositions, and methods for increasing CFTR activity | Chemistry; Metallurgy | 14 | Active |
| US9790219B2 | Compounds, compositions, and methods for increasing CFTR activity | Chemistry; Metallurgy | 14 | Active |
| US5872101A | Methods of treating neurodegenerative disorders using protease inhibitors | Human Necessities | 13 | Expired |
| US6051684A | Methods of treating neurodegenerative disorders using protease inhibitors | Human Necessities | 12 | Expired |
| US6967196B1 | Sulfonamide compounds and uses thereof | Chemistry; Metallurgy | 10 | Expired |
| US10017503B2 | Compounds, compositions, and methods for increasing CFTR activity | Chemistry; Metallurgy | 10 | Active |
| US5863902A | Methods of treating neurodegenerative disorders using protease inhibitors | Human Necessities | 10 | Expired |
| US5962419A | Peptide and peptide analog protease inhibitors | Human Necessities | 9 | Expired |
| US10174014B2 | Compounds, compositions, and methods for increasing CFTR activity | Chemistry; Metallurgy | 8 | Active |
| US6362009B1 | Solid phase synthesis of heterocycles | Chemistry; Metallurgy | 8 | Expired |
| US9738610B2 | Indazole derivatives and uses thereof | Chemistry; Metallurgy | 7 | Active |
| US10548878B2 | Compounds, compositions, and methods of increasing CFTR activity | Chemistry; Metallurgy | 6 | Active |
| US10344023B2 | Derivatives of 3-heteroarylisoxazol-5-carboxylic amide useful for the treatment of inter alia cystic fibrosis | Chemistry; Metallurgy | 6 | Active |
| US10392372B2 | Compounds, compositions, and methods for increasing CFTR activity | Physics | 6 | Active |
| US10550106B2 | Compounds, compositions, and methods for modulating CFTR | Chemistry; Metallurgy | 6 | Active |
| US9096594B2 | Kinase inhibitors and methods of use thereof | Chemistry; Metallurgy | 6 | Active |
| US10137122B2 | Kinase inhibitors and methods of use thereof | Chemistry; Metallurgy | 6 | Active |
| US10392378B2 | Derivatives of 5-phenyl- or 5-heteroarylathiazol-2-carboxylic amide useful for the treatment of inter alia cystic fibrosis | Physics | 6 | Active |
| US7569592B2 | Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5 | Chemistry; Metallurgy | 5 | Expired |
| US7105533B2 | Fused heterobicyclo substituted phenyl metabotropic glutamate-5 modulators | Chemistry; Metallurgy | 5 | Expired |
| US5455271A | Tight-binding inhibitors of leukotriene A.sub.4 hydrolase | Chemistry; Metallurgy | 5 | Expired |
| US6015879A | Peptide and peptide analog protease inhibitors | Human Necessities | 4 | Expired |
| US9850262B2 | Proteasome activity enhancing compounds | Chemistry; Metallurgy | 4 | Active |
| US10662207B2 | Compounds, compositions, and methods for modulating CFTR | Chemistry; Metallurgy | 4 | Active |
| US5804560A | Peptide and peptide analog protease inhibitors | Human Necessities | 4 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.